Evidence map›Paper›PMID 35347229›Full record

ArticleMucosal immunology2022

Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses.

Jens Wittner, Sebastian R Schulz, Tobit D Steinmetz, Johannes Berges, Manuela Hauke, William M Channell, Adam F Cunningham, Anja E Hauser, Andreas Hutloff, Dirk Mielenz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Cells · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jens WittnerDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Sebastian R SchulzDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Tobit D SteinmetzDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Johannes BergesDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Manuela HaukeDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
William M ChannellInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Adam F CunninghamInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Anja E HauserDepartment of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Andreas HutloffInstitute of Immunology and Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Kiel, Germany.
Dirk MielenzDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Hans-Martin JäckDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Wolfgang SchuhDivision of Molecular Immunology, Department of Internal Medicine 3, Nikolaus-Fiebiger Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. wolfgang.schuh@uk-erlangen.de.ORCID http://orcid.org/0000-0002-6606-8388
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Birmingham · GBHumboldt-Universität zu Berlin · DEUniversity Hospital Schleswig-Holstein · DE

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Krüppel-like factor 2 (KLF2) is a potent regulator of lymphocyte differentiation, activation and migration. However, its functional role in adaptive and humoral immunity remains elusive. Therefore, by using mice with a B cell-specific deletion of KLF2, we investigated plasma cell differentiation and antibody responses. We revealed that the deletion of KLF2 resulted in perturbed IgA plasma cell compartmentalization, characterized by the absence of IgA plasma cells in the bone marrow, their reductions in the spleen, the blood and the lamina propria of the colon and the small intestine, concomitant with their accumulation and retention in mesenteric lymph nodes and Peyer's patches. Most intriguingly, secretory IgA in the intestinal lumen was almost absent, dimeric serum IgA was drastically reduced and antigen-specific IgA responses to soluble Salmonella flagellin were blunted in KLF2-deficient mice. Perturbance of IgA plasma cell localization was caused by deregulation of CCR9, Integrin chains αM, α4, β7, and sphingosine-1-phosphate receptors. Hence, KLF2 not only orchestrates the localization of IgA plasma cells by fine-tuning chemokine receptors and adhesion molecules but also controls IgA responses to Salmonella flagellin.

Indexed as

Immunoglobulin AKruppel-Like Transcription FactorsPeyer's PatchesPlasma CellsAnimalsFlagellinIntestinal MucosaMiceFlagellinImmunoglobulin AKlf2 protein, mouseKruppel-Like Transcription Factors

Identifiers

PMID35347229
PMCPMC9259478
OpenAlexW4220722667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.